Investing.com - Revolution Med reported on Monday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Revolution Med announced earnings per share of $-0.87 on revenue of $3.36M. Analysts polled by Investing.com anticipated EPS of $-0.84 on revenue of $5.97M.
Revolution Med shares are down 5.02% from the beginning of the year and are trading at $19.77 , down-from-52-week-high.
Revolution Med follows other major Healthcare sector earnings this month
Revolution Med's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar